BCR-ABL1 Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase (NCT05007873) | M.D. Anderson Cancer Center | 2021-10-21 |
Track BCR-ABL1 Positive automatically
Every clearance here is in the API, with alerts when new ones post.